Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Deandra Dagen

Nurse Practitioner, Obstetrics & Gynecology Chandler, AZ Nurse Practitioner

NPI 1700191426 CMS profile 10448721

1950 W Frye Rd, Chandler, AZ 85224

Open in the dashboard

General payments

$1,869

91 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Deandra Dagen of Chandler, AZ is reported in the CMS Open Payments database as having received $1,869 across 91 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Nurse Practitioner, Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $234 12
2024 General $333 10
2023 General $442 18
2022 General $376 21
2021 General $484 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Deandra Dagen
  • Nurse Practitioner, Obstetrics & Gynecology median
  • Middle half of Nurse Practitioner, Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Deandra Dagen were reported at $234. Among 1,030 Nurse Practitioner, Obstetrics & Gynecology profiles paid that year, the median was $151 and the middle half received between $51 and $371.

Show as a table
Year Deandra Dagen Nurse Practitioner, Obstetrics & Gynecology median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $484 $135 $40–$338 $132
2022 $376 $143 $45–$386 $149
2023 $442 $153 $54–$411 $160
2024 $333 $140 $45–$326 $164
2025 $234 $151 $51–$371 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Bayer HealthCare Pharmaceuticals Inc. $277 14 payments
  2. Astellas Pharma US Inc $277 6 payments
  3. Daiichi Sankyo Inc. $169 10 payments
  4. Hologic, LLC $152 8 payments
  5. Biogen, Inc. $126 5 payments
  6. Organon LLC $123 7 payments
  7. AbbVie, Inc. $118 7 payments
  8. Mayne Pharma Inc. $115 7 payments
  9. CooperSurgical, Inc. $98 3 payments
  10. Mylan Pharmaceuticals Inc. $61 4 payments
  11. Other $354 20 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,676 89 payments
  2. Education $193 2 payments
Products named General payments · program years 2021–2025
  1. Mirena $225 11 payments
  2. Kyleena Womens Health $205 10 payments
  3. INJECTAFER $169 10 payments
  4. Zurzuvae $126 5 payments
  5. Aptima $93 4 payments
  6. Veozah $84 4 payments
  7. ORILISSA $76 5 payments
  8. PARAGARD T 380A $64 1 payment
  9. Xulane $61 4 payments
  10. Kyleena Women's Health $52 3 payments
  11. Other $804 47 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

34

Median for Nurse Practitioner: 389

Drug cost

$1,783

Median for Nurse Practitioner: $21,885

Branded share of claims

0%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Estradiol Generic 34 $1,783

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$6,440

Medicare's payments for the services billed

Medicare patients

47

Average age 68

Services billed

137

47 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 60%
Arthritis 49%
Osteoporosis 32%
Diabetes 26%
Chronic kidney disease 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Veozah
  • Astellas Pharma US Inc $24
$24 — —
GARDASIL 9
  • Merck Sharp & Dohme Corporation $7
$7 — —
GARDASIL
  • Merck Sharp & Dohme Corporation $7
$7 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

91 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Obstetrics & Gynecology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record